SBTX — Skinbiotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Skinbiotherapeutics, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.

	R2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4.61	1.8	1.31	0.801	4.78
Net Total Accounts Receivable
Net Total Receivables	0.453	0.405	0.375	0.341	1.41
Total Inventory
Prepaid Expenses
Total Current Assets	5.06	2.33	1.72	1.67	7.11
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.143	0.127	0.173	0.116	0.728
Net Goodwill
Net Intangible Assets
Total Assets	5.73	3.08	2.59	5.22	12.1
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.405	0.509	0.53	1.8	1.47
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.52	0.61	0.599	2.25	2.71
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	5.22	2.48	1.99	2.97	9.42
Total Liabilities & Shareholders' Equity	5.73	3.08	2.59	5.22	12.1
Total Common Shares Outstanding